We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Protherics | LSE:PTI | London | Ordinary Share | GB0007029209 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 45.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/12/2008 20:14 | A historic day for long suffering PTI holders. Let's hope the new combined BTG/PTI brings better fortune. Amen | mre | |
04/12/2008 14:05 | good luck guys and gals! | adejuk | |
04/12/2008 08:28 | See you all on the BTG bb. Merry Xmas and a prosperous New Year to all. HT | hot_topic | |
03/12/2008 23:28 | Farewell PTI! I hope the faith we have all had in the Company's Pipeline is fullfilled within BTG. Keep the faith! | fhmktg | |
01/12/2008 15:33 | The main BTG BB is here:- | baht | |
21/11/2008 08:50 | Comments about BTG buying PTI 'on the cheap' seem misplaced. If PTI is 'going cheap' why has not some other big pharma - or anyone else come to that - bought it with their petty cash at a higher price? Why didn't PTI acquire BTG? Why not take the BTG paper and buy more in the market if you think they got it on the cheap. Good luck all. | bodgit | |
20/11/2008 09:37 | bobby.ifa I applaud your candid honesty. Best of luck. Johnac PS I can see no discussion on BTG thread. Why, I wonder? | johnac | |
20/11/2008 09:08 | 100% correct Greekman. The Company have effectively distructed shareholder value, the very opposite of what they're hired to do. This was going to be a major play in my personal finances,however it has cost me dearly. I'm totally dissolutioned with equities after 15 years of playing the market and being a complete net loser. Enough is enough now- I'm going to build a cash pile here on. | bobby.ifa | |
20/11/2008 08:46 | Greekman Agreed. HT | hot_topic | |
20/11/2008 08:28 | Results. Financial Highlights, show everything up that should be up and everything down that should be down, except.....Net cash decrease of £9.6m (2007: increase of £6.9m) in line with expectations, providing a cash position of £28.1m (2007: £46.9m) This in the stage of Protherics as a company was/is expected. Who needs BTG. OK it will give PTI more pulling power so to speak, but would still have liked them (PTI) to have chanced going it alone. Yes a big gamble but worth it. In my opinion. BTG have by far the best part of the deal. PTI have sold themselves out far too cheaply. All IMHO of course. | greekman | |
17/11/2008 10:50 | Looking at BTG thread, I see very little mentioned. Where is the debate? Regards Johnac | johnac | |
17/11/2008 09:37 | the_doctor I agree, I would find it difficult to believe that the FSA is not looking at this. Before the announcement of the proposed merger and with no prior indication the share price reaches 58p and stays there. Then six weeks later it is announced the offer is valued at 58p. It couldn't be more obvious that someone knew and passed it on. HT | hot_topic | |
17/11/2008 09:23 | Quality always wins through..... | rivaldo | |
15/11/2008 09:43 | the_doctor, It happens all the time in the city and very few people ever get their collar tugged for it .... | red ninja | |
15/11/2008 09:01 | PTI bid was clearly leaked by someone in the know! They should worry whenever they hear a knock at the door Cerrito - 14 Nov'08 - 09:04 - 2658 of 2659 Today's Telegraph quote Richard Ralph, former Governor of the Falkland Islands and a past British ambassador to both Peru and Romania, has been fined £117,691.41 by the City regulator after it was discovered he asked a friend to buy shares in Monterrico Metals. Mr Ralph became chairman of Monterrico in August 2006, shortly before the £93m mining business was taken over by China's Zijin Consortium. The FSA found that during the takeover talks Mr Ralph asked his friend Filip Boyen to buy about £30,000 of shares in order to conceal his true identity. At the time, Mr Ralph was closely involved in the takeover talks and was and would have been expected to publicly disclose any dealing in company shares. As well as buying the shares for Mr Ralph, Mr Boyen also bought shares for himself worth £77,162.05. After a takeover deal was announced to the market, Mr Boyen sold both men's holdings, generating a collective profit of £42,174.36. Once the FSA began to investigate suspicious trading prior to the takeover, Mr Ralph voluntarily contacted the FSA and admitted to insider dealing. Mr Boyen was fined £81,982.95 and sources said both fines would have been as much as a third higher had it not been for the full co-operation and early settlement by the pair. unquote | the_doctor | |
13/11/2008 07:25 | Nioe Buy verdict in today's Independent - 300p being suggested for the combined entity? "BTG Our view: Buy Share price: 152.5p (+1.25p) Biotech and life science groups are traditionally not the type of companies investors should be buying in a downturn. In good times, such groups can raise money with abandon, pumping more and more into research without ever really having to worry too much about turning good science into profitable drugs. In bad times, however, the sector can become a graveyard of good ideas as investors get more nervous about groups that are great at developing, but not proficient at making profits. BTG, with good reason, sees itself a different kettle of fish. The good news for investors is it is profitable: yesterday's interim results showed the firm, which specialises in neuroscience treatments, returned a pre-tax profit of £3.4m in the six months to the end of September, which comes largely from licensing deals. While the profit figure was down on the same period last year, it is the recurring royalty revenues from these licensing deals, which jumped by 17 per cent to £24.2m, that the group says is salient. BTG's shares have soared by 34.5 per cent in the past month, which chief executive, Louise Makin, says proves that investors see the company differently to the rest of the sector. There is probably more than a degree of truth in that, especially as most other biotech groups have struggled to attract buyers in the same period. The biggest, if unlikely, risk, warns Dr Makin, is not achieving the successful integration of Protherics, an immunotherapeutic group BTG has acquired for £218m. If merged well, the combined company will have an impressive pipeline of deals, with some suggesting a share price of £3 should not be out of the question. A punt on any biotech firm is a risky investment, but those wanting exposure to the sector could do worse than buy BTG. With £67.5m of cash on the balance sheet and an ambition to hit the FTSE 250, investors could do very nicely. Buy." | rivaldo | |
12/11/2008 09:52 | Maak, PTI disappears at 08:00 on 4th December and you should automatically have the BTI shares effective that day. I suggest you check on the PTI website where there are documents spelling everything out (www.protherics.com) | mre | |
12/11/2008 08:56 | When do my 10000 pti shares convert? and do they automatically convert to btg without doing anything? | maak128 | |
12/11/2008 07:11 | geat results at BTG.I am now well pleased with the merger and we should see a blue day (well hopefully) | wywcu1 | |
11/11/2008 21:45 | maak they convert to 2910 btg shares, at today's price that's £4394.10 so your holding or selling price is decided by that. my break even price is £1.79 so i'm sitting tight for a bit, the share price does seem to be going north at a reasonable rate though. golly | golly1980 | |
11/11/2008 21:02 | i have 10000 shares in pti- do i sell? what happens to my current holding? | maak128 | |
11/11/2008 11:33 | The PTI EGM on the merger is supposed to be today - hopefully a RNS later today. | mre |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions